Navigation Links
Fox Chase study shows that weakened T-cell receptor signals change T-cell lineage

The immune system is a marvel of versatility, creating a variety of cells that develop in different ways to protect the body. To carry out these tasks, immune cells follow a career path that forks at various points in their development. In a report in the May 2005 issue of Immunity, Fox Chase Cancer Center scientists led by immunologists David L. Wiest, Ph.D. and Dietmar J. Kappes, Ph.D., show that cell-receptor signaling strength influences which course certain immature immune cells will take, suggesting a flexible new model for commitment to one lineage or another.

The first, most basic career choice made by precursors of the adaptive arm of the immune system is whether to adopt the B-cell or T-cell fate. Both originate from stem cells in the bone marrow, but B cells mature there while T cells migrate to the thymus gland, which governs their development.

"The recognition and destruction of invading pathogens by T lymphocytes is essential to the ability of humans to resist disease," said Wiest. "T cells recognize these invaders by means of a surface structure called the T-cell antigen receptor complex, or TCR."

Two distinct lineages of T cells utilize distinct types of TCR complexes. One lineage employs pairs of TCR proteins termed alpha-beta while the other uses the TCR gamma-delta pair of proteins. The alpha-beta and gamma-delta pairs of proteins represent the "eyes" of the TCR complex and enable these distinct types of T cells make unique contributions to our ability to resist disease.

The more numerous T cells of the alpha-beta lineage provide protection against infectious diseases either by helping B cells generate antibodies against external agents (helper T cells) or by directly attacking and destroying cells infected by foreign invaders (killer T cells). Gamma-delta T cells migrate from the thymus to epithelial tissues such as skin and the linings of the lung. While their precise role remains poorly understood, they perform vi tal protective functions. Certain lung infections easily cleared from normal laboratory mice are a death sentence for those lacking gamma-delta T cells.

Despite their clear importance in resisting disease, the processes controlling the generation of gamma-delta T cells have remained mysterious until recently. As Robert Frost put it, Wiest pointed out:
"Two roads diverged in a wood, and I--
I took the one less traveled by,
And that has made all the difference."

"Gamma-delta T cells represent the road less traveled," Wiest said. "However, the role of the TCR in determining lineage is controversial, particularly whether different forms of TCR predetermine a cell's fate and whether or not their signals control the choice."

In the new study, Wiest and his colleagues use several models to manipulate the signaling strength of the gamma-delta TCR. A strong signal, produced in the presence of a specific binding substance, or ligand, directs immature T cells almost exclusively to the gamma-delta lineage. However, weakening the signal promotes alpha-beta lineage development.

"The signal strength determines the level of expression of early growth response (Egr) proteins, with cells choosing the gamma-delta lineage expressing far greater quantities of Egr proteins than those adopting the alpha-beta lineage," explained Wiest. "Egr proteins regulate which cellular genes are turned on or off so we think that high-level expression of Egr proteins instructs cells to express the set of cellular genes necessary to become a gamma-delta T cell."

Understanding the development of critical components of the immune system can lead to scientific and medical advances in stimulating desirable immune responses and halting unwanted ones.

"Although their precise function is still unclear, delta-gamma T cells seem to form the first line of response against external disease-causing agents, including bacterial infections, tissue damage and stress," Wiest said. "Laboratory mice unable to make delta-gamma T cells heal skin injuries more slowly.

"Immune surveillance, the body mechanism that detects potential cancers and destroys them before their presence is evident to us, may be one function of the delta-gamma lineage, since gamma-delta T cells appear to be particularly adept at combating skin cancers," Wiest added.


'"/>

Source:Fox Chase Cancer Center


Related biology news :

1. Fox Chase Cancer Center scientists identify immune-system mutation
2. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
3. Bioartificial kidney under study at MCG
4. W.M. Keck Foundation funds study of friendly microbes
5. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
6. Genome-wide mouse study yields link to human leukemia
7. Clam embryo study shows pollutant mixture adversely affects nerve cell development
8. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
9. Same mutation aided evolution in many fish species, Stanford study finds
10. Sequencing of marine bacterium will help study of cell communication
11. Genetically modified rice in China benefits farmers health, study finds
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
(Date:6/15/2016)... York , June 15, 2016 ... new market report titled "Gesture Recognition Market by Application ... Forecast, 2016 - 2024". According to the report, the  ... 11.60 billion in 2015 and is estimated to ... USD 48.56 billion by 2024.  Increasing ...
Breaking Biology News(10 mins):
(Date:12/5/2016)...  Renova™ Therapeutics, a biotechnology company developing gene ... chronic diseases, announced that Catherine Bovenizer , ... Officer (CFO), effective today. Ms. Bovenizer ... in financial management for a variety of public ... recently, Ms. Bovenizer was the Vice President of ...
(Date:12/5/2016)... , Dec 5, 2016 Research and ... "DNA Sequencing - Technologies, Markets and Companies" to ... , ... briefly reviews basics of human genome variations, development of sequencing ... described as well as companies developing them. Various applications of ...
(Date:12/4/2016)... , Dec. 3, 2016  In five studies ... Hematology (ASH) Annual Meeting and Exposition in ... engineering methods to improve the delivery of life-saving treatments ... new methods are designed to carry therapies directly to ... most, which could provide a substantial advantage over traditional, ...
(Date:12/2/2016)... -- The Multiple Myeloma Research Foundation (MMRF) today announced that ... —the largest and most comprehensive study driving new genomic ... presented at the 58 th American Society of ... San Diego from December 3-6. The new ... as identify pathways and targets for new drug development. ...
Breaking Biology Technology: